tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ashwani Verma, 129 are a BUY (72.07%), 44 are a HOLD (24.58%), 6 are a SELL (3.35%).
Analyst Ashwani Verma, currently employed at UBS, carries an average stock price target met ratio of 60.91% that have a potential upside of 26.94% achieved within 167 days.
Ashwani Verma’s has documented 358 price targets and ratings displayed on 30 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on VTRS, Viatris at 05-Oct-2026.
Analyst best performing recommendations are on CRNX (CRINETICS PHARMACEUTICALS).
The best stock recommendation documented was for CRNX (CRINETICS PHARMACEUTICALS) at 7/2/2026. The price target of $55 was fulfilled within 5 days with a profit of $12.77 (30.24%) receiving and performance score of 60.48.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 02-Apr-2025
$132
$0.13 (0.10%)
$132
1 years 6 months 25 days ago
(02-Apr-2025)
27/29 (93.1%)
$0.13 (0.10%)
494
Hold Since 28-Feb-2025
$132
$0.13 (0.10%)
$132
1 years 7 months 29 days ago
(28-Feb-2025)
12/15 (80%)
$3.8 (2.96%)
738
Buy Since 10-Dec-2020
$132
$0.13 (0.10%)
$100
1 years 8 months 3 days ago
(24-Feb-2025)
14/15 (93.33%)
$3.43 (2.67%)
274
Hold Since 21-Feb-2025
$100
1 years 8 months 6 days ago
(21-Feb-2025)
24/25 (96%)
$-27.19 (-21.38%)
152
Hold Since 08-Aug-2024
$132
$0.13 (0.10%)
$87
1 years 8 months 22 days ago
(05-Feb-2025)
8/9 (88.89%)
$4.97 (3.91%)
227
Which stock is Ashwani Verma most bullish on?
Which stock is Ashwani Verma most reserved on?
What Year was the first public recommendation made by Ashwani Verma?
